Hypoactive Sexual Desire Disorder (HSDD) Treatment Market 2019-2027 – Credence Research | Industry Size, Share & Forecast

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Is Expected To Expand At A CAGR of 5.2%

SAN JOSE, United States - August 14, 2019 /MarketersMedia/ —

The latest market report published by Credence Research, Inc. “Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global hypoactive sexual desire disorder (HSDD) treatment market is set to expand at a CAGR of 5.2% from 2019 to 2027.

Browse the full report Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis 2019 – 2027 at https://www.credenceresearch.com/report/hypoactive-sexual-desire-disorder-hsdd-treatment-market

Market Insights

Hypoactive sexual desire disorder (HSDD) is currently on a rise in adult women population manifested by low self confidence and less connected with their partners. Recent approval of Vyleesi will provide essential momentum for the HSDD market growth. Currently 2 drugs such as BP101 and Prasterone 6.5 mg vaginal insert are under phase 3 clinical trial are being investigated for its safety and efficacy for treatment of HSDD.

Hypoactive sexual desire disorder is the most common type of sexual dysfunction occurring in adult women worldwide manifested by lack of sex interest for a period of six months or more due to personal distress or fluctuating sex hormones during the menstrual cycle. Accurate diagnosis of the symptoms manifested in hypoactive sexual desire disorder (HSDD) is very critical to finalize the treatment regimen which is either psychotherapy or pharmacotherapy. The PLISSIT model (Permission, Limited Information, Specific Suggestions and Intensive Therapy) aids in initial screening of HSDD. Psychotherapy is suggested to patients showing positive response to counseling sessions with sex therapist.

Request Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Research Sample: https://www.credenceresearch.com/sample-request/59843

Pharmacotherapy comprises of buspirone and bupropion off label treatment for HSDD in women suffering with low libido associated with anxiety and depression. Testosterone transdermal patches are used as an off label treatment in premenopausal and postmenopausal women with HSDD. Flibanserin is currently the only drug approved by USFDA for treating HSDD in premenopausal women owing to its multifunctional serotonin agonist and antagonist pharmacodynamic profile.

North America is the largest regional segment in the hypoactive sexual desire disorder (HSDD) treatment market representing a market share of 38.5%. The chief attributing factors responsible for its supreme market growth are growing incidence of low libido in the female population owing to increasing stress in daily life and fluctuating sex hormones during the menstrual cycle. Domicile of key players such as AMAG Pharmaceutcials, Allergan, Plc., S1 Biopharma, Inc. and Sprout Pharmaceuticals, Inc. further propel the market growth in North America regional segment. Europe is placed in the second position with a market share of 32.4% primarily due to affordable reimbursement scenario for the medicines prescribed for the treatment of hypoactive sexual desire disorder (HSDD). Asia Pacific holding a market share of 15.2% will be growing at a rapid pace during the forecast period owing to rising prevalence of HSDD in working women population and developing healthcare infrastructure.

Pharmaceutical companies providing pharmacotherapy for treating hypoactive sexual desire disorder are AMAG Pharmaceutcials, Allergan, Plc., Ivix, LLX., EndoCeutics, Inc., Emotional Brain BV., S1 Biopharma, Inc. and Sprout Pharmaceutcials, Inc.

Key Market Movements:

Growing incidence of low sex drive in women population worldwide
Affordable reimbursement scenario for pharmacotherapy employed in the treatment of HSDD
Recent approval of Vyleesi and strong product pipeline will further propel the HSDD market growth during the forecast period

Request Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Research Sample: https://www.credenceresearch.com/sample-request/59843

TOC:

1. Preface...

2. Executive Summary...

3. Hypoactive Sexual Desire Disorder Treatment Market: Dynamics and Future Outlook...

Chapter 4. Global Hypoactive Sexual Desire Disorder Treatment Market, by Therapy
4.1. Overview
4.2. Buspirone
4.3. Bupropion
4.4. Testosterone
4.5. Flibanserin
4.6. Bremelanotide
4.7. Cognitive Behavior Therapy
4.8. Pipeline Analysis
4.8.1. Phase III Drug
4.8.1.1. Prasterone 6.5 mg Vaginal Insert
4.8.1.2. BP101

Chapter 5. Global Hypoactive Sexual Desire Disorder Treatment Market, by Geography
5.1. Overview
5.2. North America Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017 – 2027
5.2.1. North America Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.2.2. North America Hypoactive Sexual Desire Disorder Treatment Market, by Country, 2017 – 2027 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017– 2027
5.3.1. Europe Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.3.2. Europe Hypoactive Sexual Desire Disorder Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017 – 2027
5.4.1. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.4.2. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific...

Chapter 6. Company Profiles
6.1. AMAG Pharmaceuticals
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Allergan, Plc.
6.3. Ivix LLX
6.4. EndoCeutics, Inc.
6.5. Emotional Brain BV ...

Browse the full report Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis 2019 – 2027 at https://www.credenceresearch.com/report/hypoactive-sexual-desire-disorder-hsdd-treatment-market

About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Phone: +18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/hypoactive-sexual-desire-disorder-hsdd-treatment-market-2019-2027-credence-research-industry-size-share-forecast/88908175

Source: MarketersMedia

Release ID: 88908175

Other Sports News

Van Rooyen shoots 64, leads by 1 at Scandinavian Invitation

Aug 24, 2019

GOTHENBURG, Sweden — South African golfer Erik van Rooyen birdied five of his last six holes to shoot a 6-under 64 on Saturday and take a one-stroke lead into the final round of the Scandinavian Invitation. Van Rooyen is bidding to win his first European Tour title after posting two second-place finishes among five top-10s this season, his first on the circuit since graduating from the second-tier Challenge Tour. He was on 13-under 197 overall after the third round, one clear of Matt Fitzpatrick of England (69), Ashun Wu of China (67) and Wade Ormsby (65). Henrik Stenson, playing in...

Homers by Crawford, Narváez help Mariners past Blue Jays 7-4

Aug 24, 2019

SEATTLE — Omar Narváez and J.P. Crawford supported Justus Sheffield with a couple big swings. Narváez and Crawford homered, and the Seattle Mariners beat the Toronto Blue Jays 7-4 on Friday night for their fifth win in six games. Narváez led off the second inning with his 18th homer and Crawford did the same leading off the fifth, belting his sixth of the year. "We had a ton of chances to put up more runs than we did tonight," manager Scott Servais said. "A lot of good at-bats up and down the lineup." The production by Narváez, Crawford and Kyle...

Gregorius helps Yankees pound Dodgers 10-2

Aug 24, 2019

LOS ANGELES — Didi Gregorius hit a grand slam off Hyun-Jin Ryu and added a solo shot to help the Yankees set a club record for homers in a month, and New York routed the Los Angeles Dodgers 10-2 Friday night in a matchup of the two teams with the best records in baseball. Aaron Judge, Gary Sánchez and Gleyber Torres also homered as the Yankees ended a four-game skid. They have a major league-leading 57 homers in August, their most in any month. Starting on five days' rest, James Paxton (10-6) allowed two runs in 6 2/3 innings to...

Castro, Marlins rally from 7 runs down, beat Phillies 19-11

Aug 24, 2019

MIAMI — A wild victory for the Marlins was tempered by some disappointing injury news. Starlin Castro homered twice and drove in five runs, and Miami spotted the Philadelphia Phillies a seven-run lead before rallying to win 19-11 on Friday night, its highest-scoring game at Marlins Park. "To be able to come from seven down early, obviously I would have never thought it would have ended like this with the way it started," Marlins manager Don Mattingly said. Castro's big night began with him on the bench. He entered as a pinch-hitter in the fifth and delivered with his fifth...

Pirates rally past Reds in 9th for 3-2 win

Aug 24, 2019

PITTSBURGH — Pablo Reyes plays baseball with an unabashed joy, something in short supply these days for the Pittsburgh Pirates. For one brief moment Friday night, the 5-foot-8 utility player provided a dash of it for his beleaguered team, capping a ninth-inning rally with a game-ending single to lift the Pirates to a 3-2 victory over the Cincinnati Reds. The Pirates won for just the ninth time in 39 games since the All-Star break by chipping away at Reds closer Raisel Iglesias (2-9). Pittsburgh put together three straight singles to start the ninth, the last a flare to shallow center...

Sukan360 is a proud Malaysian Sports website enthusiastic in our local players and bring Malaysian sports news first and foremost.

Contact us: sales@sukan360.com

Soccer Racing Shootings Golf Sports Governance Men's Sports Women's Sports Press Releases